About the Cancer Genomics Session
Changes in the DNA of cells cause cancer. Cancer genomics identifies genetic changes, defines molecular subtypes, and develops precision medicine techniques for cancer treatment using technologies such as sequencing. Genome sequencing is providing physicians greater information about the causes of cancer and modifying how some cancers are treated. Genomic assays allow for the identification of somatic and germline abnormalities in individual tumor samples, are becoming more widely employed in clinical diagnostics as a means of determining therapeutic alternatives. Genomic-based tests are increasingly being used as part of evidence-based diagnosis to help patients with cancer get better care.
- Precision Oncology
- Genomic Heterogeneity and Tumors
- Liquid Biopsy
- Immunogenomics
Topics Covered in Cancer Genomics
Somatic Mutation Profiling
Germline Testing
Whole-Genome Sequencing
Molecular Subtyping
Tumor Heterogeneity
Mutational Signatures
Related Scientific Sessions at CIOC 2027
Why Attend the Cancer Genomics Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Cancer Genomics work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Cancer Genomics research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Cancer Genomics track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Cancer Genomics Conference 2027 — FAQs
What is the Cancer Genomics track at CIOC 2027?
The Cancer Genomics track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Cancer Genomics. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Cancer Genomics sessions?
Cancer researchers and clinicians, educators and students with an interest in Cancer Genomics are all welcome — whether presenting or attending.
Can I present my research in the Cancer Genomics track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Cancer Genomics sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Cancer Genomics track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.